A first-in-class inhibitor of Hsp110 molecular chaperones of pathogenic fungi
2023 · Nature Communications · 20 citations
https://doi.org/10.1038/s41467-023-38220-2
L
Liqing Hu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
314
Citations
10
h-index
10
i10-index
Liqing Hu is an academic researcher from Hunan Normal University. The author has contributed to research in topics: Pulmonary Hypertension Research and Treatments & Heat shock proteins research & Renin-Angiotensin System Studies. The author has an h-index of 10, co-authored 37 publications.
ORCID: 0000-0003-3592-488XPapers by this author
worksInhibition of Hsp110-STAT3 interaction in endothelial cells alleviates vascular remodeling in hypoxic pulmonary arterial Hypertension model
2023 · Respiratory Research · 19 citations
https://doi.org/10.1186/s12931-023-02600-5
Exploration of small-molecule inhibitors targeting Hsp110 as novel therapeutics
2025 · Drug Discovery Today · 0 citations
https://doi.org/10.1016/j.drudis.2024.104287
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat